Status:
COMPLETED
Impact of n-3 Polyunsaturated Fatty Acids in a Protein-enriched Diet With Low GI in Type 2 Diabetes Patients
Lead Sponsor:
Medical University of Vienna
Collaborating Sponsors:
Enervit Spa (company)
Conditions:
Overweight
Obese
Eligibility:
All Genders
18-75 years
Brief Summary
Type 2 diabetes is tightly associated with overweight and obesity. Inflammatory processes are crucial triggers for insulin resistance that paves the way to type 2 diabetes. In a previous study the inv...
Eligibility Criteria
Inclusion
- overweight or obesity AND
- insulin resistant OR pre-diabetes OR type 2 diabetes
Exclusion
- changes in anti-diabetic medication in the lat two months
- acute illness during the last two weeks
- HIV infection
- hepatitis of other clinically significant hepatic disease other than non-alcoholic hepatic steatosis
- severe or insufficiently treated cardiovascular, renal (GFR-MDRD \< 60 ml/min) or pulmonary disease
- Macroproteinuria (\> 300 mg/g creatinine)
- clinically significant or insufficiently treated thyroid disease
- anemia
- active malignant disease
- inborn or acquired coagulopathy
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01474603
Start Date
November 1 2011
End Date
March 1 2015
Last Update
March 16 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. Medicine III, Medical University of Vienna
Vienna, Austria, 1090